Mani Mohindru Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mani Mohindru.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mani Mohindru. Mani Mohindru is a Chief Strategy Officer in CURIS INC ($CRIS) and a Sr. VP, Corp. Strategy & IR in CURIS INC ($CRIS) and a CFO & Chief Strategy Officer in Cara Therapeutics, Inc. ($CARA) and a Director in CytomX Therapeutics, Inc. ($CTMX).
Address: C/O CURIS, INC. 4 MAGUIRE ROAD LEXINGTON 02421 MA
Companies in which Mani Mohindru is an Insider
Cara Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mani Mohindru: CFO & Chief Strategy Officer
Holdings: 22,196 shares
Current Value: $361,795
Latest Transaction: Dec 04 2019
$CARA Market Capitalization: $449.33M
$CARA Previous Close: $16.30
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CURIS INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Mani Mohindru: Chief Strategy Officer, Sr. VP, Corp. Strategy & IR
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 16 2017
$CRIS Market Capitalization: $368.24M
$CRIS Previous Close: $2.73
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CytomX Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mani Mohindru: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Dec 18 2020
$CTMX Market Capitalization: $410.61M
$CTMX Previous Close: $11.50
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Mani Mohindru
Sentiment: All, CARA, CRIS, CTMX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 18 2020 | CTMX | CytomX Therapeutic ... | Mohindru Mani | Director | Option Exercise | A | 7.45 | 40,000 | 298,000 | 40,000 | |
| Dec 04 2019 | CARA | Cara Therapeutics, ... | Mohindru Mani | CFO & Chief Strateg ... | Sell | S | 17.05 | 4,755 | 81,073 | 17,441 | 22.2 K to 17.4 K (-21.42 %) |
| Dec 04 2019 | CARA | Cara Therapeutics, ... | Mohindru Mani | CFO & Chief Strateg ... | Grant | A | 0.00 | 8,333 | 0 | 22,196 | 13.9 K to 22.2 K (+60.11 %) |
| Jul 17 2019 | CARA | Cara Therapeutics, ... | Mohindru Mani | CFO & Chief Strateg ... | Option Exercise | M | 14.06 | 37,431 | 526,280 | 299,444 | |
| Jul 17 2019 | CARA | Cara Therapeutics, ... | Mohindru Mani | CFO & Chief Strateg ... | Sell | S | 25.00 | 37,431 | 935,775 | 13,863 | 51.3 K to 13.9 K (-72.97 %) |
| Jul 17 2019 | CARA | Cara Therapeutics, ... | Mohindru Mani | CFO & Chief Strateg ... | Buy | M | 14.06 | 37,431 | 526,280 | 51,294 | 13.9 K to 51.3 K (+270.01 %) |
| May 30 2019 | CARA | Cara Therapeutics, ... | Mohindru Mani | CFO & Chief Strateg ... | Sell | S | 21.39 | 2,496 | 53,389 | 13,863 | 16.4 K to 13.9 K (-15.26 %) |